Page last updated: 2024-11-05

thiabendazole and Stevens-Johnson Syndrome

thiabendazole has been researched along with Stevens-Johnson Syndrome in 2 studies

Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research Excerpts

ExcerptRelevanceReference
"The rashes were compatible with erythema multiforme and Stevens-Johnson syndrome and developed in the three siblings within 1-3 weeks after the intake of thiabendazole."3.72Severe drug rashes in three siblings simultaneously. ( Bahna, SL; Johnson-Reagan, L, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson-Reagan, L1
Bahna, SL1
Robinson, HM1
Samorodin, CS1

Other Studies

2 other studies available for thiabendazole and Stevens-Johnson Syndrome

ArticleYear
Severe drug rashes in three siblings simultaneously.
    Allergy, 2003, Volume: 58, Issue:5

    Topics: Antinematodal Agents; Child; Child, Preschool; Drug Hypersensitivity; Female; Humans; Male; Siblings

2003
Thiabendazole-induced toxic epidermal necrolysis.
    Archives of dermatology, 1976, Volume: 112, Issue:12

    Topics: Adult; Female; Humans; Stevens-Johnson Syndrome; Thiabendazole; Trichuriasis

1976